These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15606344)

  • 1. Vaccine for hepatitis A safe for HIV patients.
    Expert Rev Vaccines; 2004 Dec; 3(6):625-8. PubMed ID: 15606344
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine vaccination of HIV-infected patients against hepatitis A: should we discriminate before vaccination according to ethnicity?
    Górgolas M; Rivas P; Guerrero ML
    Clin Infect Dis; 2005 Jul; 41(2):272-3. PubMed ID: 15983933
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
    Laurence JC
    Am J Med; 2005 Oct; 118 Suppl 10A():75S-83S. PubMed ID: 16271546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A and B virus immunization in HIV-infected persons.
    Laurence J
    AIDS Read; 2006 Jan; 16(1):15-7. PubMed ID: 16433468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis A: is universal vaccination justified in Mexico?].
    Kershenobich D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S69-70. PubMed ID: 9102786
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of prophylactic vaccination on hepatitis A spreading in the North Causcasus district of RF MIA internal troops].
    Rikhter VV; Baryshev SN; Sultanova ER; Artiukov RM; Gurin SN
    Voen Med Zh; 2002 Dec; 323(12):42-3. PubMed ID: 12602263
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis.
    Shire NJ; Welge JA; Sherman KE
    Vaccine; 2006 Jan; 24(3):272-9. PubMed ID: 16139398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inactivated antihepatitis A vaccine].
    Escolar M; Sádaba B; Honorato J
    Rev Med Univ Navarra; 1995; 40(2):110-4. PubMed ID: 7569545
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Don't forget the hepatitis A vaccine.
    Thompson SC; Le Leu LA
    Med J Aust; 1997 Aug; 167(4):228-9. PubMed ID: 9293273
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylaxis of viral hepatitis in HIV-HCV co-infected patients].
    Estepo C; Colombato L; Guerrina C
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S46-7; discussion S74-82. PubMed ID: 16862859
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunogenicity and safety of three consecutive lots on an inactivated hepatitis A vaccine: a double-blind, immunogenicity and safety of three consecutive lots on a inactivated hepatitis A vaccine:a double-blind, randomized and controlled trial in children].
    Jiang WP; Wang YL; Chen WY; Xu WG; Chen JT; Wang X; Liu Y; Yin WD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):556-9. PubMed ID: 19040036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical inquiries: Who should get hepatitis A vaccination?
    Brown R; Cable K; Sams R
    J Fam Pract; 2005 Jul; 54(7):624-5; discussion 624. PubMed ID: 16009092
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].
    García-Doval I
    Actas Dermosifiliogr; 2007 Mar; 98(2):88-90. PubMed ID: 17397593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.